BLENDED INTENSIVE PROGRAMME: prorogata la scadenza

Martedì, 17 Dicembre 2024

Avvisi di selezione per i BIP Translational research in MDR:

How to move from preclinical research to clinical benefits  Drug development, repurposing and formulation against MDR, and relative toxicological aspects – DesignDrugs2MDR:  scadenza prorogata al 10 gennaio 2025